Related references
Note: Only part of the references are listed.Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model
Brian D. Piccolo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Direct injection LC-MS/MS method for the determination of teicoplanin in human plasma
Kwang-Youl Kim et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
Cholsoon Jang et al.
NATURE MEDICINE (2016)
Acylcarnitines: potential implications for skeletal muscle insulin resistance
Celine Aguer et al.
FASEB JOURNAL (2015)
Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: A population-based study
Kyung Hee Yi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes
E. Panzhinskiy et al.
DIABETOLOGIA (2013)
Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells
Gholamreza Taheripak et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Diabetes Mellitus-Associated Vascular Impairment Novel Circulating Biomarkers and Therapeutic Approaches
Dimitris Tousoulis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Dimitris Tousoulis et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
ConsensusPathDB: toward a more complete picture of cell biology
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2011)
Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: The putative role of asymmetric dimethylarginine (ADMA)
M. Siervo et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
Maike Anderssohn et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Latika Sibal et al.
CURRENT CARDIOLOGY REVIEWS (2010)
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Ralph A. DeFronzo et al.
DIABETES CARE (2009)
Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production
Arthur J. Pope et al.
PHARMACOLOGICAL RESEARCH (2009)
Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma
Keun Na et al.
PROTEOMICS (2009)
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity
Karsten Sydow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Comparison of LC-NMR and conventional NMR for structure elucidation in drug metabolism studies
Gregory S. Walker et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance
K. Toutouzas et al.
HORMONE AND METABOLIC RESEARCH (2008)
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony
Mark A. Herman et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss
T McLaughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Pathway studio - the analysis and navigation of molecular networks
A Nikitin et al.
BIOINFORMATICS (2003)
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
NN Chan et al.
DIABETOLOGIA (2002)
Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment
R Sreekumar et al.
DIABETES (2002)
Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region
S Dadke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients
A Krook et al.
DIABETES (2000)